Steven Eck

898 total citations
20 papers, 396 citations indexed

About

Steven Eck is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Steven Eck has authored 20 papers receiving a total of 396 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 5 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Steven Eck's work include Immunotherapy and Immune Responses (6 papers), Biosimilars and Bioanalytical Methods (5 papers) and Single-cell and spatial transcriptomics (4 papers). Steven Eck is often cited by papers focused on Immunotherapy and Immune Responses (6 papers), Biosimilars and Bioanalytical Methods (5 papers) and Single-cell and spatial transcriptomics (4 papers). Steven Eck collaborates with scholars based in United States, United Kingdom and Switzerland. Steven Eck's co-authors include Laurence A. Turka, Jennifer J. Stewart, Virginia Litwin, Cherie Green, Alessandra Vitaliti, Teri Oldaker, Nithianandan Selliah, David Chang, Andrew D. Wells and Sandip Pravin Patel and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Steven Eck

20 papers receiving 383 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steven Eck United States 12 255 153 116 41 27 20 396
Ilseyar Akhmetzyanova Germany 9 239 0.9× 150 1.0× 94 0.8× 85 2.1× 16 0.6× 10 381
Natko Nuber Switzerland 10 204 0.8× 152 1.0× 106 0.9× 31 0.8× 19 0.7× 13 311
Marte Fauskanger Norway 10 378 1.5× 310 2.0× 138 1.2× 33 0.8× 21 0.8× 11 525
Seungwon Lee South Korea 11 147 0.6× 75 0.5× 115 1.0× 59 1.4× 21 0.8× 17 316
Bettina P. Iliopoulou United States 10 323 1.3× 250 1.6× 101 0.9× 55 1.3× 16 0.6× 15 531
Sabine Hoepner Switzerland 6 181 0.7× 150 1.0× 111 1.0× 53 1.3× 11 0.4× 8 305
Kazushi Tanimoto Japan 9 150 0.6× 157 1.0× 55 0.5× 76 1.9× 47 1.7× 24 296
Katrin Deiser Germany 10 336 1.3× 240 1.6× 85 0.7× 36 0.9× 18 0.7× 14 470
Jena E. Moseman United States 8 240 0.9× 168 1.1× 96 0.8× 15 0.4× 11 0.4× 14 355
Sneh Sharma United States 7 222 0.9× 172 1.1× 103 0.9× 122 3.0× 11 0.4× 9 369

Countries citing papers authored by Steven Eck

Since Specialization
Citations

This map shows the geographic impact of Steven Eck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven Eck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven Eck more than expected).

Fields of papers citing papers by Steven Eck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven Eck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven Eck. The network helps show where Steven Eck may publish in the future.

Co-authorship network of co-authors of Steven Eck

This figure shows the co-authorship network connecting the top 25 collaborators of Steven Eck. A scholar is included among the top collaborators of Steven Eck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven Eck. Steven Eck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Monaghan, Sara A., Steven Eck, Silvia T. Bunting, et al.. (2024). Flow cytometry assay modifications: Recommendations for method validation based on CLSI H62 guidelines. Cytometry Part B Clinical Cytometry. 108(3). 252–266. 3 indexed citations
2.
Åstrand, Annika, Johan Mattsson, Komal Agrawal, et al.. (2024). A comparative study of blood cell count in four automated hematology analyzers: An evaluation of the impact of preanalytical factors. PLoS ONE. 19(5). e0301845–e0301845. 2 indexed citations
3.
Selliah, Nithianandan, Steven Eck, Cherie Green, et al.. (2023). Flow Cytometry Method Validation Protocols. Current Protocols. 3(8). e868–e868. 9 indexed citations
4.
Carneiro, Benedito A., Dmitriy Zamarin, Thomas U. Marron, et al.. (2022). Abstract CT183: First-in-human study of MEDI1191 (mRNA encoding IL-12) plus durvalumab in patients (pts) with advanced solid tumors. Cancer Research. 82(12_Supplement). CT183–CT183. 14 indexed citations
5.
Mathews, Joel, Lakshmi Amaravadi, Steven Eck, et al.. (2022). Best practices for the development and fit-for-purpose validation of biomarker methods: a conference report. SHILAP Revista de lepidopterología. 8(1). 6 indexed citations
6.
Glisson, Bonnie S., Rom S. Leidner, Robert L. Ferris, et al.. (2020). Safety and Clinical Activity of MEDI0562, a Humanized OX40 Agonist Monoclonal Antibody, in Adult Patients with Advanced Solid Tumors. Clinical Cancer Research. 26(20). 5358–5367. 63 indexed citations
7.
Sarikonda, Ghanashyam, Mélissa Mathieu, Anil Pahuja, et al.. (2020). Best practices for the development, analytical validation and clinical implementation of flow cytometric methods for chimeric antigen receptor T cell analyses. Cytometry Part B Clinical Cytometry. 100(1). 79–91. 25 indexed citations
8.
Sommer, Ülrike, Steven Eck, Jennifer J. Stewart, et al.. (2020). High‐sensitivity flow cytometric assays: Considerations for design control and analytical validation for identification of Rare events. Cytometry Part B Clinical Cytometry. 100(1). 42–51. 31 indexed citations
9.
Glisson, Bonnie S., Rom S. Leidner, Robert L. Ferris, et al.. (2018). Safety and clinical activity of MEDI0562, a humanized OX40 agonist monoclonal antibody, in adult patients with advanced solid tumors. Annals of Oncology. 29. viii410–viii410. 20 indexed citations
10.
Selliah, Nithianandan, Steven Eck, Cherie Green, et al.. (2018). Flow Cytometry Method Validation Protocols. Current Protocols in Cytometry. 87(1). e53–e53. 55 indexed citations
11.
Hammond, Scott A., Qun Du, Kathy Mulgrew, et al.. (2015). Human OX40 ligand fusion protein (MEDI6383) as a potent OX40 agonist and immuno-modulator in vitro and in vivo.. Journal of Clinical Oncology. 33(15_suppl). 3056–3056. 1 indexed citations
12.
Forero, Andres, Mehdi Hamadani, Thomas J. Kipps, et al.. (2013). Safety and disease response to MEDI-551, an anti-CD19 antibody, in chronic lymphocytic leukemia patients previously treated with rituximab. Journal for ImmunoTherapy of Cancer. 1(S1). 3 indexed citations
13.
Hamadani, Mehdi, Andres Forero, Thomas J. Kipps, et al.. (2013). MEDI-551, an anti-CD19 antibody active in chronic lymphocytic leukemia (CLL) patients previously treated with rituximab.. Journal of Clinical Oncology. 31(15_suppl). 7045–7045. 5 indexed citations
14.
Cao, Tinghua, Wei Zhou, Weihong Wang, et al.. (2009). Ex vivo expanded human CD4+CD25+Foxp3+ regulatory T cells prevent lethal xenogenic graft versus host disease (GVHD). Cellular Immunology. 258(1). 65–71. 40 indexed citations
15.
Eck, Steven, Peimin Zhu, Marion Pepper, et al.. (2006). Developmental Alterations in Thymocyte Sensitivity Are Actively Regulated by MHC Class II Expression in the Thymic Medulla. The Journal of Immunology. 176(4). 2229–2237. 18 indexed citations
16.
Gómez-Navarro, Jesús, A. Sharma, Viviana Bozón, et al.. (2006). Dose and schedule selection for the anti-CTLA4 monoclonal antibody ticilimumab in patients (pts) with metastatic melanoma. Journal of Clinical Oncology. 24(18_suppl). 8032–8032. 10 indexed citations
17.
Eck, Steven & Laurence A. Turka. (2001). Adoptive transfer enables tumor rejection targeted against a self-antigen without the induction of autoimmunity.. PubMed. 61(7). 3077–83. 11 indexed citations
18.
19.
Eck, Steven & Laurence A. Turka. (1999). Generation of protective immunity against an immunogenic carcinoma requires CD40/CD40L and B7/CD28 interactions but not CD4 + T cells. Cancer Immunology Immunotherapy. 48(6). 336–341. 21 indexed citations
20.
Eck, Steven, David Chang, Andrew D. Wells, & Laurence A. Turka. (1997). Differential Down-Regulation Of CD28 By B7-1 And B7-2 Engagement1. Transplantation. 64(10). 1497–1499. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ilseyar Akhmetzyanova Breakdown of academic impact, for papers by Natko Nuber Breakdown of academic impact, for papers by Marte Fauskanger Breakdown of academic impact, for papers by Seungwon Lee Breakdown of academic impact, for papers by Bettina P. Iliopoulou Breakdown of academic impact, for papers by Sabine Hoepner Breakdown of academic impact, for papers by Kazushi Tanimoto Breakdown of academic impact, for papers by Katrin Deiser Breakdown of academic impact, for papers by Jena E. Moseman Breakdown of academic impact, for papers by Sneh Sharma
Rankless by CCL
2026